ROI Widget

Patients are only 50 to 65 percent adherent with their medication, and poor adherence reduces a clinical trial’s ability to detect a treatment effect if one exists. The highest and best use of IMC’s intelligent packaging solutions is early detection of non-adherence and correction through self-discovery, education and motivational counselling.

Modeling the interrelationship between statistical power, sample size and medication adherence shows that for every percent adherence is increased, a trial's sample size can be reduced by two percent while holding statistical power constant. With 35 to 50 percent non-adherence there’s lots of room for improvement – and ROI.